Fort Lauderdale, Florida--(Newsfile Corp. - September 25, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce its participation in the U.S. Hemp Roundtable's recent advocacy meetings in Washington, D.C. The meetings, aimed at advancing legislation to support the hemp industry, included key discussions with lawmakers as well as health and agriculture staffers from several congressional offices.
Representing Flora at the meetings was Clifford Starke, Chairman and Chief Executive Officer, who alongside other industry leaders, advocated for clearer federal regulations, improved market access, and stronger protections for hemp-derived products. Flora's participation underscores the Company's commitment to being at the forefront of legislation and regulatory processes shaping the U.S. hemp industry.
The meetings focused on a range of important topics, including the need for clearer federal oversight of hemp-derived cannabinoids, and ensuring the future of the U.S. hemp industry amid evolving agricultural and health-related policies.
Mr. Starke expressed his optimism about the outcomes of the meetings: "as one of the leading voices in the industry, Flora is proud to have been part of the U.S. Hemp Roundtable's important advocacy work. We were provided with a valuable platform to address the critical issues facing the industry today. We push for sensible and effective regulations that protect consumers, ensure product safety, and enable long-term growth for the entire sector."
"Our industry is working tirelessly to bring sensible, science-based hemp regulations to the forefront of Washington's agenda," said Jonathan Miller, General Counsel for the U.S. Hemp Roundtable. "Through collaborative advocacy and education, we are ensuring that policymakers understand the immense potential of hemp and CBD products, while promoting a regulatory framework that prioritizes safety, consumer confidence, and innovation. Our goal is to create a clear and fair path forward that supports the growth of the hemp industry and benefits farmers, businesses, and consumers alike."
Mr. Starke is the Chairman of the U.S. Hemp Roundtable. It is a coalition of leading companies and organizations with the objective of ensuring the long-term viability of the hemp industry in the United States.
About Flora Growth Corp.
Flora Growth Corp.'s mission is to become the leading NASDAQ small-cap international cannabis company. FLGC is a cannabis-focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit www.floragrowth.com.
https://justcbdstore.com/
https://www.vesselbrand.com/
https://justcbdstore.uk/
https://www.phatebo.de/home-en
https://www.australianvaporizers.com.au/
Investor Relations:
Investor Relations ir@floragrowth.com
Clifford Starke Clifford.Starke@floragrowth.com
Media:
media@floragrowth.com
Cautionary Statement Concerning Forward-Looking Statements
This press release contains "forward-looking statements," as defined by U.S. federal securities laws. Forward-looking statements reflect Flora's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar expressions generally identify forward-looking statements. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled "Risk Factors" in Flora's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the "SEC") on March 28, 2024, as such factors may be updated from time to time in Flora's periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov/edgar. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora's filings with the SEC. While forward-looking statements reflect Flora's good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/224320
